Strategy For Reversing Type 1 Diabetes Supported By Ongoing Clinical Trial
19:00 EDT 9 Aug 2012 | Medical News Today
A phase I clinical trial has confirmed that use of a generic vaccine to raise levels of an immune system modulator can cause the death of autoimmune cells targeting the insulin-secreting cells of the pancreas and temporarily restore insulin secretion..
Original Article: Strategy For Reversing Type 1 Diabetes Supported By Ongoing Clinical Trial
More From BioPortfolio on "Strategy For Reversing Type 1 Diabetes Supported By Ongoing Clinical Trial"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
